Clinical Hepatocellular Carcinoma

The molecular targets of interest have expanded from angiogenesis to cancer cell-directed oncogenic signaling pathways for advanced HCC treatment. The feasibility of combining locoregional therapies and targeted agents, and the use of novel agents after curative treatments are currently under active investigation. Finally, the therapeutic strategy has shifted from monotherapy to combination targeted therapy.

  • Partial Hepatectomy
  • Clinical Analysis of Cells
  • Intra - arterial Chemotherapy
  • AFP Blood Testing

Related Conference of Clinical Hepatocellular Carcinoma

July 07-08, 2025

20th Euro-Global Gastroenterology Conference

Zurich, Switzerland
July 30-31, 2025

16th International Conference on Liver Diseases & Hepatology

Aix-en-Provence, France

Clinical Hepatocellular Carcinoma Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in